Literature DB >> 7860072

Regional localization of the human EGF-like growth factor CRIPTO gene (TDGF-1) to chromosome 3p21.

S Saccone1, A Rapisarda, S Motta, R Dono, G M Persico, G Della Valle.   

Abstract

The CRIPTO gene encodes a novel human growth factor structurally related to epidermal growth factor. We localized the CRIPTO gene to chromosome 3p21 by fluorescence in situ hybridization with a cosmid clone containing 40 kb of the CRIPTO genomic region (TDGF-1). To suppress hybridization to CRIPTO-related sequences, present in multiple copies in the human genome, hybridization was carried out in the presence of unlabeled CRIPTO cDNA in excess over the probe. Our finding confirms the provisional mapping of the CRIPTO gene to chromosome 3, and assigns it precisely to a chromosomal region involved in several rearrangements occurring in malignancy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7860072     DOI: 10.1007/bf00209409

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  7 in total

1.  A high resolution in situ hybridization technique for the direct visualization of labeled G-banded early metaphase and prophase chromosomes.

Authors:  M E Chandler; J J Yunis
Journal:  Cytogenet Cell Genet       Date:  1978

2.  Differential expression of epidermal growth factor-related proteins in human colorectal tumors.

Authors:  F Ciardiello; N Kim; T Saeki; R Dono; M G Persico; G D Plowman; J Garrigues; S Radke; G J Todaro; D S Salomon
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

3.  Expression of cripto, a novel gene of the epidermal growth factor gene family, leads to in vitro transformation of a normal mouse mammary epithelial cell line.

Authors:  F Ciardiello; R Dono; N Kim; M G Persico; D S Salomon
Journal:  Cancer Res       Date:  1991-02-01       Impact factor: 12.701

4.  Inhibition of CRIPTO expression and tumorigenicity in human colon cancer cells by antisense RNA and oligodeoxynucleotides.

Authors:  F Ciardiello; G Tortora; C Bianco; M P Selvam; F Basolo; G Fontanini; F Pacifico; N Normanno; R Brandt; M G Persico
Journal:  Oncogene       Date:  1994-01       Impact factor: 9.867

5.  Isolation and characterization of the CRIPTO autosomal gene and its X-linked related sequence.

Authors:  R Dono; N Montuori; M Rocchi; L De Ponti-Zilli; A Ciccodicola; M G Persico
Journal:  Am J Hum Genet       Date:  1991-09       Impact factor: 11.025

6.  Assignment of the human heterogeneous nuclear ribonucleoprotein A1 gene (HNRPA1) to chromosome 12q13.1 by cDNA competitive in situ hybridization.

Authors:  S Saccone; G Biamonti; S Maugeri; M T Bassi; G Bunone; S Riva; G Della Valle
Journal:  Genomics       Date:  1992-01       Impact factor: 5.736

7.  Molecular characterization of a gene of the 'EGF family' expressed in undifferentiated human NTERA2 teratocarcinoma cells.

Authors:  A Ciccodicola; R Dono; S Obici; A Simeone; M Zollo; M G Persico
Journal:  EMBO J       Date:  1989-07       Impact factor: 11.598

  7 in total
  4 in total

1.  Mapping of the mouse Tdgf1 gene and Tdgf pseudogenes.

Authors:  G Liguori; L De Gregorio; M Tucci; C T Lago; A Barra; T A Dragani; M Persico
Journal:  Mamm Genome       Date:  1997-07       Impact factor: 2.957

2.  Characterization of the mouse Tdgf1 gene and Tdgf pseudogenes.

Authors:  G Liguori; M Tucci; N Montuori; R Dono; C T Lago; F Pacifico; F Armenante; M G Persico
Journal:  Mamm Genome       Date:  1996-05       Impact factor: 2.957

3.  Role of Oncofetal Protein CR-1 as a Potential Tumor Marker for Oral Squamous Cell Carcinoma.

Authors:  Anu Jain; Sumanth Kumar Mallupattu; Reetu Thakur; Satyawati Mohindra; Amanjit Bal; Ashim Das; Sushmita Ghoshal; Arnab Pal
Journal:  Indian J Clin Biochem       Date:  2020-06-12

4.  Cripto haploinsufficiency affects in vivo colon tumor development.

Authors:  Emilia Giorgio; Annamaria Liguoro; Luca D'Orsi; Sara Mancinelli; Antonio Barbieri; Giuseppe Palma; Claudio Arra; Giovanna L Liguori
Journal:  Int J Oncol       Date:  2014-04-30       Impact factor: 5.650

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.